C-Met expression pattern in uterine leiomyoma

被引:0
|
作者
Boynukalin, F. K. [1 ]
Comunoglu, C. [2 ]
Turkmen, I. [3 ]
Kuzey, G. M. [2 ]
Gueler, O. T. [4 ]
Baykal, C. [5 ]
机构
[1] Anatolia Womens Hlth Ctr, Ankara, Turkey
[2] Near East Univ, Fac Med, Dept Pathol, Nicosia, Cyprus
[3] Florence Nightingale Hosp, Dept Pathol, Istanbul, Turkey
[4] Near East Univ, Fac Med, Dept Obstet & Gynecol, Nicosia, Cyprus
[5] Florence Nightingale Hosp, Dept Obstet & Gynecol, Istanbul, Turkey
来源
关键词
Hepatocyte growth factor; c-Met receptor; Uterine leiomyoma; HEPATOCYTE GROWTH-FACTOR; HUMAN PANCREATIC-CANCER; MET/HGF RECEPTOR; HUMAN MYOMETRIUM; TUMOR-GROWTH; EPITHELIAL-CELLS; CARCINOMA-CELLS; SCATTER FACTOR; PROTOONCOGENE; OVEREXPRESSION;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: Growth factors take place in the formation and growth of uterine leiomyomas (LMs). Transforming growth factor beta (TGF-beta), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2), and insulin-like growth factor (IGF) contribute to the pathophysiology of LMs when they bind with a specific membrane receptor and transmit a signal into the cell. Little is known about hepatocyte growth factor (HGF) and its receptor system c-Met in formation and growth of uterine LMs. The aim of this study was to evaluate the c-Met receptor expression on human myometrium and uterine LMs. Materials and Methods: The study was performed on human myometrium and uterine LMs. Expression of c-Met receptor was evaluated by immunohistochemical analysis. Results: Overexpression of c-Met was found in all LM cases and in none of normal myometrium samples c-Met overexpression was seen. Conclusion: HGF and c-Met receptor complex seem to have role in development of uterine LMs.
引用
收藏
页码:254 / 257
页数:4
相关论文
共 50 条
  • [1] Hepatocyte growth factor and c-Met expression in uterine serous cancer
    Bishop, E.
    Lengyel, E. R.
    Yamada, S. D.
    Montag, A.
    Tretiakova, M.
    Temkin, S. M.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S75 - S76
  • [2] c-Met expression in hemangioblastomas
    Revercomb, Carolyn H.
    Zagzag, David
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2007, 66 (05): : 442 - 442
  • [3] c-Met expression in hemangioblastomas
    Revercomb, Carolyn H.
    Zagzag, David
    FASEB JOURNAL, 2007, 21 (05): : A392 - A392
  • [4] The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinoma
    Bishop, Erin A.
    Lengyel, Ernst R.
    Yamada, S. Diane
    Montag, Anthony
    Temkin, Sarah M.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : 218 - 223
  • [5] Prevalence of c-Met overexpression (c-Met plus ) and Impact of Prior Lines of Treatment on c-Met Protein Expression in NSCLC
    Motwani, M.
    Panchabhai, S.
    Bar, J.
    Girard, N.
    Bradbury, P.
    Lu, S.
    Jin, J.
    Hotson, A.
    Maag, D.
    Planchard, D.
    Camidge, D. R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1169 - S1170
  • [6] Expression of c-MET in invasive meningioma
    Yun, S.
    Koh, J.
    Lee, K.
    Seo, A.
    Nam, K.
    Choe, G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 174 - 174
  • [7] Expression of c-Met in laryngeal carcinoma
    M. Sawatsubashi
    Eizaburo Sasatomi
    Hiroyuki Mizokami
    Osamu Tokunaga
    Takemoto Shin
    Virchows Archiv, 1998, 432 : 331 - 335
  • [8] The Expression Pattern of c-Met in Squamous Cervical Intraepithelial Neoplasms: Preliminary Study
    Comunoglu, Cem
    Kuzey, Gamze Mocan
    Baykal, Cem
    Boynukalin, Kubra
    Guler, Tolga
    Uygur, Dilek
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 : A204 - A204
  • [9] Expression of c-Met in laryngeal carcinoma
    Sawatsubashi, M
    Sasatomi, E
    Mizokami, H
    Tokunaga, O
    Shin, T
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1998, 432 (04): : 331 - 335
  • [10] C-MET EXPRESSION IN MALIGNANT MESOTHELIOMAS
    Illei, Peter
    Sharma, Rajni
    Cowan, Morgan
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S804 - S804